<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Advaxis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of cancer. Our goal is to develop cancer immunotherapies that teach the body to recognize tumors as a threat and do so in a way that minimizes side effects associated with traditional chemotherapy and radiation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth A. Berlin
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    ObsEva SA

    ObsEva SA

    Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company foc...

    Founded in November 2012, ObsEva is a clinical-...

    Filing Type:    PU
    I-PASS Patient Safety Institute, Inc.

    I-PASS Patient Safety Institute, Inc.

    We help save lives by improving verbal and written communications that occur betwe...

    We help save lives by improving verbal and writ...

    Amount Raised:    $149,055.00
    Fundraising Status:    EC
    Filing Type:    CF
    Patterson Companies, Inc.

    Patterson Companies, Inc.

    Patterson Companies Inc. (Nasdaq: PDCO) connects dental and animal health customer...

    Patterson Companies Inc. (Nasdaq: PDCO) connect...

    Filing Type:    PU
    Halozyme Therapeutics, Inc.

    Halozyme Therapeutics, Inc.

    Halozyme is a clinical-stage biotechnology company focused on developing and comme...

    Halozyme is a clinical-stage biotechnology comp...

    Filing Type:    PU
    IDEXX Laboratories, Inc.

    IDEXX Laboratories, Inc.

    IDEXX Laboratories, Inc. is a member of the S&P 500ÂŽ Index and is a leader in pet...

    IDEXX Laboratories, Inc. is a member of the S&P...

    Filing Type:    PU
    Participant Assistive Products

    Participant Assistive Products

    We make affordable assistive products, starting with a groundbreaking supportive w...

    We make affordable assistive products, starting...

    Amount Raised:    $211,262.00
    Fundraising Status:    EC
    Filing Type:    CF
    Corcept Therapeutics Incorporated

    Corcept Therapeutics Incorporated

    Corcept is a pharmaceutical company engaged in the discovery, development and comm...

    Corcept is a pharmaceutical company engaged in ...

    Filing Type:    PU
    Translate Bio, Inc.

    Translate Bio, Inc.

    Translate Bio is a leading mRNA therapeutics company developing a new class of pot...

    Translate Bio is a leading mRNA therapeutics co...

    Filing Type:    PU
    Rigel Pharmaceuticals, Inc.

    Rigel Pharmaceuticals, Inc.

    Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, d...

    Rigel Pharmaceuticals, Inc. is a biotechnology ...

    Filing Type:    PU
    MacroGenics, Inc.

    MacroGenics, Inc.

    MacroGenics is a clinical-stage biopharmaceutical company focused on discovering a...

    MacroGenics is a clinical-stage biopharmaceutic...

    Filing Type:    PU
    Genomic Health, Inc.

    Genomic Health, Inc.

    Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-bas...

    Genomic Health, Inc. (NASDAQ: GHDX) is the worl...

    Filing Type:    PU
    Regeneron Pharmaceuticals, Inc.

    Regeneron Pharmaceuticals, Inc.

    We are a leading science and technology company that delivers life-transforming me...

    We are a leading science and technology company...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.